Investment Summary |
|
|---|---|
| Date | 2021-07-01 |
| Target | ProtaGene |
| Sector | Life Science |
| Investor(s) | Ampersand Capital Partners |
| Sellers(s) | Zukunftsfonds Heilbronn |
| Deal Type | Secondary Buyout |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 61 of 86 |
| Sector: Life Science M&A | 29 of 43 |
| Type: Secondary Buyout M&A Deals | 3 of 8 |
| Country: Germany M&A | 1 of 2 |
| Year: 2021 M&A | 5 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-12 |
Nexcelom Bioscience
Lawrence, Massachusetts, United States Nexcelom Bioscience is a designer, manufacturer, and marketer of innovative Cellometer and Celigo image cytometry products designed for cell analysis in life science and biomedical research. Nexcelom Bioscience was founded in 2003 and is based in Lawrence, Massachusetts. |
Sell | $260M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-14 |
LakePharma
San Carlos, California, United States LakePharma is a biologics company specializing in antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing, and bioanalytics. LakePharma focuses on integrated platforms to support projects throughout the drug discovery process. LakePharma was founded in 2009 and is based in San Carlos, California. |
Sell | - |
| Category | Family Office |
|---|---|
| Founded | 2005 |
| PE ASSETS | 200M USD |
| Size | Small |
| Type | Sector Agnostic |
Zukunftsfonds Heilbronn is a family backed growth investor focused on emerging companies in the Heilbronn area of Germany. Zukunftsfonds Heilbronn was established in 2005 and is headquartered in Heilbronn, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 6 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Secondary Buyout M&A Deals | 2 of 2 |
| Country: Germany M&A | 6 of 6 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-10-12 |
PL BioScience
Aachen, Germany PL BioScience is an expert in cell culture supplements derived from human Platelets. PL BioScience's mission is to enhance the advances in cellular research and therapy with forward-looking cell growth promoters. PL BioScience was founded in 2015 and is based in Aachen, Germany. |
Buy | - |
